文献速递糖尿病

2型糖尿病患者脂蛋白水平与下肢外周动脉疾病风险:SURDIAGENE研究

Plasma concentrations of lipoproteins and risk of lower-limb peripheral artery disease in people with type 2 diabetes: the SURDIAGENE study.
PubMed 文献 · Diabetologia · 2021-01-06

SURDIAGENE队列纳入1468例2型糖尿病患者,基线检测总胆固醇、HDL-C、甘油三酯及载脂蛋白等。HDL-C和ApoA-I最高三分位与基线主要PAD患病率较低相关,总胆固醇/HDL-C比值最高三分位与患病率较高相关;随访中位7.1年,HDL-C和ApoA-I最高三分位与PAD发病风险较低相关,总胆固醇/HDL-C比值和非HDL-C最高三分位与发病风险较高相关。

要点

  • HDL-C和ApoA-I较高与2型糖尿病患者主要PAD患病及发病风险较低独立相关。
  • 总胆固醇/HDL-C比值较高与主要PAD患病及发病风险较高独立相关。
  • 非HDL-C较高与主要PAD发病风险较高独立相关。

核心结论

  • HDL-C、ApoA-I、总胆固醇/HDL-C比值或非HDL-C与2型糖尿病患者主要PAD的患病率或发病率存在独立关联。

研究设计与样本

  • SURDIAGENE队列研究,纳入1468例2型糖尿病患者(女性42%,平均年龄65±11岁,基线糖尿病病程14±10年)。
  • 基线采用比色法或质谱法检测总胆固醇、HDL-C、甘油三酯及ApoA-I、ApoA-II、ApoB-100、Apo(a)浓度。
  • 采用logistic和Cox比例风险回归模型,按脂蛋白三分位分组估计基线主要PAD患病或随访期间发病的OR或HR及95%CI,并校正关键混杂因素。

主要发现

  • 129例(8.8%)有基线主要PAD病史。
  • 基线主要PAD患病率在HDL-C最高三分位(vs最低三分位)较低(OR 0.42 [95%CI 0.26, 0.71],p=0.001),ApoA-I最高三分位较低(OR 0.39 [95%CI 0.23, 0.67],p=0.0007),总胆固醇/HDL-C比值最高三分位较高(OR 1.95 [95%CI 1.18, 3.24],p=0.01)。
  • 基线无PAD病史的1339例中,随访中位7.1(4.4-10.7)年期间97例(7.2%)发生PAD,对应9685人年,发病率为9.8(95%CI 8.0, 12.0)/1000人年。
  • PAD发病风险在HDL-C最高三分位(vs最低三分位)较低(HR 0.54 [95%CI 0.30, 0.95],p=0.03),ApoA-I最高三分位较低(HR 0.50 [95%CI 0.28, 0.86],p=0.01),总胆固醇/HDL-C比值最高三分位较高(HR 2.81 [95%CI 1.61, 5.04],p=0.0002),非HDL-C最高三分位较高(HR 1.80 [95%CI 1.06, 3.12],p=0.03)。

临床怎么用

  • 在2型糖尿病患者中,HDL-C和ApoA-I较高、总胆固醇/HDL-C比值和非HDL-C较低可能提示主要PAD风险较低。
  • 评估2型糖尿病患者PAD风险时,除LDL-C外可关注HDL-C、ApoA-I、总胆固醇/HDL-C比值和非HDL-C。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS/HYPOTHESIS: The lipid profile has not been fully investigated in individuals with peripheral artery disease (PAD). We aimed to evaluate the relationship between plasma concentrations of lipoproteins and the prevalence of lower-limb PAD at baseline and its incidence during follow-up in people with type 2 diabetes. METHODS: Plasma concentrations of total cholesterol, HDL-cholesterol, triacylglycerol and apolipoprotein (Apo) A-I, ApoA-II, ApoB-100 and Apo(a) were measured at baseline using colorimetric or MS methods in the SURDIAGENE cohort. Total cholesterol/HDL-cholesterol ratio, non-HDL-cholesterol and LDL-cholesterol were estimated using computation formulas. Logistic and Cox proportional hazard regression models were fitted to estimate OR or HR, with related 95% CI, for baseline prevalence or incidence of major PAD (lower-limb amputation or requirement of revascularisation) during follow-up by increasing lipoprotein tertiles, after adjustment for key confounders. RESULTS: Among 1468 participants (women 42%, mean ± SD age 65 ± 11 years, duration of diabetes 14 ± 10 years at baseline), 129 (8.8%) had a baseline history of major PAD. Major PAD was less prevalent at baseline in the highest (vs lowest) tertile of HDL-cholesterol (OR 0.42 [95% CI 0.26, 0.71], p = 0.001) and ApoA-I (OR 0.39 [95% CI 0.23, 0.67], p = 0.0007), and more frequent in the highest tertile of total cholesterol/HDL-cholesterol ratio (OR 1.95 [95% CI 1.18, 3.24], p = 0.01). Among 1339 participants without a history of PAD at baseline, incident PAD occurred in 97 (7.2%) during a median (25th-75th percentile) duration of follow-up of 7.1 (4.4-10.7) years, corresponding to 9685 person-years and an incidence rate of 9.8 (95% CI 8.0, 12.0) per 1000 person-years. The risk of incident PAD was lower in the top (vs bottom) tertile of HDL-cholesterol (HR 0.54 [95% CI 0.30, 0.95], p = 0.03) or ApoA-I (HR 0.50 [95% CI 0.28, 0.86], p = 0.01) and higher in the top tertile of total cholesterol/HDL-cholesterol ratio (HR 2.81 [95% CI 1.61, 5.04], p = 0.0002) and non-HDL-cholesterol (HR 1.80 [95% CI 1.06, 3.12], p = 0.03). CONCLUSIONS/INTERPRETATION: We reported independent associations between HDL-cholesterol, ApoA-I, total cholesterol/HDL-cholesterol ratio or non-HDL-cholesterol and the prevalence or the incidence of major PAD in people with type 2 diabetes. Our findings provide a picture of lipoprotein profile in people with type 2 diabetes. Graphical abstract.

来源:Diabetologia,查看原文。版权归原作者所有。

引用

  1. Bertrand C, Saulnier PJ, Potier L, et al. Plasma concentrations of lipoproteins and risk of lower-limb peripheral artery disease in people with type 2 diabetes: the SURDIAGENE study. Diabetologia. 2021. PMID: 33409569. doi:10.1007/s00125-020-05326-x

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。